期刊文献+

周期蛋白D_1,B_1在子宫颈癌中的表达及其与临床病理间的关系 被引量:3

Expression and correlation of cyclinD_1 and cyclinB_1 in cervical cancer
下载PDF
导出
摘要 目的探讨CyclinD1,CyclinB1在子宫颈癌中的表达及其与临床病理间的关系。方法收集哈尔滨医科大学附属四院收治的38例子宫颈癌组织。采用S-P免疫组织化学法,选用CyclinD1,CyclinB1多克隆抗体,分别检测其在38例子宫颈癌中的表达率。结果 CyclinD1在38例子宫颈癌中的阳性表达率为76.32%,CyclinB1的阳性表达率为52.63%,CyclinD1的表达率高于CyclinB1,并且其表达差异有统计学意义(经Fisher确切概率法,P<0.05)。CyclinD1,CyclinB1两者的阳性表达率与淋巴结有无转移之间的关系:Cy-clinD1高于CyclinB1,但差异无统计学意义(经Fisher确切概率法,P>0.05)。结论 CyclinD1驱动细胞由G1期进入S期,促进细胞增殖,决定细胞周期进程的速度和方向,在子宫颈癌的发展过程中起着主要的作用。CyclinB1是在有丝分裂过程中起调控作用的周期蛋白,受着cyclinD1作用的影响。 Objective To detect the expression of cyclinD1 and cyclinBl in human cervical cancer and explore their correlation. Methods 38 cases of cervical cancer from January 2005 to January 2009 in the Fourth Affiliated Hospital of Harbin Medical University were collected. The expression of cyclinD1 and cyclinB1 were tested in 38 cases of cervical cancer by SP immunohistochemistry methods. Results The positive expression rate of cyclinD1 in 38 cervical cancer tissues was 76.32%, which was significantly higher than that of cyclinB1 (52.63 % ), and there was a significant difference between them( P 〈 0.05 ). CyclinD1 seemed to have a higher correlation between their expression and lymph-node metastasis, compared with cyclinB1. Actually, there was no difference between them( P 〉 0. 05 ). Conclusion CyclinD1 promotes G1/S stage process and cell proliferation, and thus play a primary role in cervical cancer progression. CyclinB1, another cyclin as a regulator in mitosis,is regulated by CyclinD1.
出处 《中国临床保健杂志》 CAS 2011年第5期469-471,F0003,共4页 Chinese Journal of Clinical Healthcare
基金 黑龙江省教育厅资助项目(12511200)
关键词 宫颈肿瘤 细胞周期蛋白D1 细胞周期蛋白B1 Uterine cervical neoplasms Cyclin D1 Cyclin B1
  • 相关文献

参考文献7

二级参考文献29

  • 1Lin X ,Erikson RL. Activation of Cdc/cyclin B and inhibition of centrosome amplification in cells depleted of plkl by SiRNA[ J]. Proc Natl Acad Sci U S A,2002,99 (13) : 8672-8676.
  • 2Weichert W, Denkert C, Schmidt M, et al. Polo-like kinase isoform expression is prongnostic factor in ovarian carcinoma[J]. Br J Cancer,2004,90(4) :815-821.
  • 3Hanisch A, Wehner A, Nigg EA, et al. Different Plkl functions show distinct dependencies on Polo-Box do main-mediated targeting [ J ]. Mol Biol Cell, 2006, 17 ( 1 ) :448-459.
  • 4Nogawa M, Yuasa T, Kimura S, et al. Intravesieal administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer[ J]. l Clin Invest, 2005,115 (4) :978-985.
  • 5Yamamoto Y, Matsuyama H, Kawauchi S, et al. Overexpression of polo-Like kinase 1 ( PLKl ) and chromosomal instability in bladder cancer[ J]. Oncology ,2006,70( 3 ) : 231-237.
  • 6Toyoshima-Morimoto F, Taniguchi E, Shinya N, et al. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase [ J ]. Nature, 2001, 410 ( 6825 ) :215-220.
  • 7Lin X, Erikson RL. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells [ J ]. Proc Natl Acad Sci USA, 2003,100 ( 10 ) : 5789 -5794.
  • 8Yokoi S,Yasui K,Saito OF,et al.A novel target gene,Skp2,within the 5p13 amplicon that is frequently detected in small cell lung cancers[ J].Am J Pathol,2002,161 (1):207-16.
  • 9Ezoe S,Matsumura I,Nakata S,et al.GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21WAF1 and p27Kip1 proteins[ J].Blood,2002,100(10):3512.
  • 10Nelsen CJ,Hansen LK,Rickheim DG,et al.Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and Skp2[ J].Oncogene,2001,20:1825-31.

共引文献16

同被引文献26

  • 1Lachat P, Shaw P, Gebhard S, et al.Expression of NDILG1, a differentiation-related gene in h-uman tissues.Histochem Cell Biol, 2002, 118(5): 399-408.
  • 2Stein S, thomasek, herzog B, et al. NDRG1 is necessary for p53- dependent apoptosis.Biol Chem, 2004, 279 (47):48930-48940.
  • 3Cangul H, Salnikow K, Yee H, et al. Enhanced overexpression of an HIF-1/Hypoxia-related protein in cancer cells. Environ Health Perspect, 2002, 110(Suppl 5):783-788.
  • 4Song JY, Lee JK, Lee NW, et al. Microarray analysis of normal cervix carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer, 2008, 18 (5): 1051-1059.
  • 5Kuhling H,Alm P,Olsson H,et al.Expression of cyclins E,A,and B,and prognosis in lymph node-negative breast cancer[J].J Pathol,2003;199(4):424-31.
  • 6Martin CM,Astbury K,O'Leary JJ.Molecular profiling of cervical neoplasia[J].Expert Rev Mol Diagn,2006;6(2):217-29.
  • 7Davy CE,Jackson DJ,Raj K,et al.Human papillomavirus type 16 E1E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes[J].J Virol,2005;79(7):3998-4011.
  • 8Cho NH,Lim SY,Kim YT,et al.G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value[J].Gynecol Oncol,2003;90(1):15-22.
  • 9马少飞,陈嘉薇,祝峰.NDRG 1基因与宫颈鳞癌发生发展及转移的关系[J].肿瘤,2008,28(3):238-241. 被引量:9
  • 10金承俊,朴大勋,金银姬,陈华.NDRG1和E-cadherin在大肠癌中的表达研究[J].哈尔滨医科大学学报,2008,42(2):153-156. 被引量:4

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部